202 related articles for article (PubMed ID: 6430141)
1. Proteinuria in gold-treated rheumatoid arthritis.
Katz WA; Blodgett RC; Pietrusko RG
Ann Intern Med; 1984 Aug; 101(2):176-9. PubMed ID: 6430141
[TBL] [Abstract][Full Text] [Related]
2. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
Horton RJ
Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
[TBL] [Abstract][Full Text] [Related]
3. Gold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
Wilson AP; Prouse PJ; Gumpel JM
Ann Rheum Dis; 1984 Jun; 43(3):511-2. PubMed ID: 6430252
[TBL] [Abstract][Full Text] [Related]
4. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
5. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral and parenteral gold therapy and placebo in the treatment of rheumatoid arthritis.
Williams HJ; Ward JR
Scand J Rheumatol Suppl; 1983; 51():92-9. PubMed ID: 6426054
[TBL] [Abstract][Full Text] [Related]
7. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO
Am J Med; 1983 Dec; 75(6A):133-7. PubMed ID: 6419595
[TBL] [Abstract][Full Text] [Related]
8. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
[TBL] [Abstract][Full Text] [Related]
9. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
[TBL] [Abstract][Full Text] [Related]
10. [Multicenter double-blind comparison of auranofin and Tauredon].
Kaik B; Bröll H
Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
[TBL] [Abstract][Full Text] [Related]
11. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
[No Abstract] [Full Text] [Related]
12. Injectable gold dermatitis and proteinuria: retreatment with auranofin.
Tosi S; Cagnoli M; Guidi G; Murelli M; Messina K; Colombo B
Int J Clin Pharmacol Res; 1985; 5(4):265-8. PubMed ID: 2932399
[TBL] [Abstract][Full Text] [Related]
13. Auranofin: experience to date.
Blodgett RC
Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
15. Failure of sodium aurothiomalate and triethyl phosphine gold to cause renal tubular injury in rheumatoid arthritis: implications for the aetiology of gold-related nephropathy.
Crisp AJ; Coughlan RJ; Clark B; Mackintosh D; Panayi GS; Sweny P; Hopper J; Varghese Z
Clin Rheumatol; 1983 Sep; 2(3):273-6. PubMed ID: 6432404
[TBL] [Abstract][Full Text] [Related]
16. Auranofin versus placebo in the treatment of rheumatoid arthritis.
Wenger ME; Alexander S; Bland JH; Blechman WJ
Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
[TBL] [Abstract][Full Text] [Related]
17. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
Davis P; Menard H; Thompson J; Harth M; Beaudet F
J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
[TBL] [Abstract][Full Text] [Related]
18. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate.
Dahl SL; Coleman ML; Williams HJ; Altz-Smith M; Kay DR; Paulus HE; Weinstein A; Kaplan S
Arthritis Rheum; 1985 Nov; 28(11):1211-8. PubMed ID: 3933523
[TBL] [Abstract][Full Text] [Related]
20. Gold concentrations and toxicity during oral gold treatment with auranofin.
Sharma RP; Smillie J; Palmer DG
Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
